Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common

Nephron

Volumn 58, Issue 1, 1991, Pages 33-36

  Roger, S D ^a   Stewart, J H ^a   Harris, D C H ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

aluminium; anaemia; desferrioxamine; erythropoietin; haemodialysis

Indexed keywords

ALUMINUM; DEFEROXAMINE; DEFEROXAMINE MESYLATE; EPRWX; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; DEPERSONALIZATION; EYE TOXICITY; FEMALE; HEMATOPOIESIS; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REYE SYNDROME;

EID: 0025822062     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000186374     Document Type: Article

References (0)